收费类受体4的结构多样性和突变挑战 作为炎症途径阻断器的对手
S K Batin Rahaman1, Sandip K Nandi2, Sudip Kumar Mandal3
1Department of Pharmaceutical Science, School of Health Science and Technology, UPES, Dehradun, Uttarakhand, India.
Drug development research
|December 18, 2024
概括
收费类受体4 (TLR4) 和骨髓分化蛋白2 (MD2) 反对者在治疗炎症疾病方面表现有前途. 最近的进展揭示了低纳米分子水平的直接抑制,提供了新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- 收费类受体4 (TLR4) 和骨髓分化蛋白2 (MD2) 形成一个复合体,通过脂多糖 (LPS) 结合触发细菌炎症.
- 这种途径的过度激活可能导致炎症性疾病,使得TLR4-MD2复合体成为关键的治疗点.
研究的目的:
- 审查用于抗炎药物开发的TLR4-MD2抗剂的近期分子进展.
- 分析TLR4-MD2结合口袋的蛋白信息学,并确定用于小分子抑制剂设计的关键残留物.
主要方法:
- 对TLR4-MD2抗剂最近的分子进展进行评估.
- 野生类型和突变TLR4-MD2结合口袋的蛋白质信息学分析.
- 对TLR4抗剂的当前临床试验状态的审查.
主要成果:
- 几种TLR4-MD2抗剂在低微和纳米分子水平上表现出直接抑制.
- 在TLR4-MD2复合体的LPS结合口袋中识别重要的残留物.
- 对小分子抑制剂的物理化学特性和结合亲和力的分析.
结论:
- TLR4-MD2复合体是新型抗炎药物的可行标.
- 蛋白质信息学为设计强大的小分子抑制剂提供了洞察力.
- 进一步开发TLR4抗剂有可能用于治疗炎症性疾病.
相关概念视频
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
T Cell Types and Functions
947
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
947
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


